+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 3Years - 18Years
All Genders
ID05951517

Study of Mycophenolate Mofetil Treatment for Children with Difficult-to-Treat Gastrointestinal Henoch-Schonlein Purpura

Led by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Updated on 2023-07-19

24

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Henoch Schf6nlein purpura HSP is the most common vasculitis in children, mostly affecting those under 10 years old. While HSP usually resolves on its own, it can cause serious complications like intestinal blockage or kidney failure. This study focuses on children with refractory gastrointestinal HSP, meaning their digestive symptoms did not improve after steroid treatment, to better understand their clinical features and assess the effects of mycophenolate mofetil MMF in these cases. The study treats patients who have not responded to steroids with the drug mycophenolate mofetil MMF. MMF is given to children aged 3 to 18 who have gastrointestinal HSP that is resistant to steroid therapy. This treatment is evaluated in an interventional study without masking or placebo comparison. Patients receive MMF after being identified as steroid-resistant. During the 6-month study period, researchers monitor the incidence of abdominal pain, vomiting blood, and bloody stools as primary outcomes. They also measure red blood cell counts in stool samples as a secondary outcome. Participants are assessed regularly to track symptom changes and treatment effects. The total participation time and follow-up ensure safety and evaluate the clinical outcome of MMF in refractory gastrointestinal HSP cases.

CONDITIONS

Brief Title

Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein Purpura

Research Team

H

Haiyan Wang, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here